Atlas Trials

Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma

Clinical trial NCT00616564 · COMPLETED

Trial details

NCT number
NCT00616564
Sponsor
Mt. Sinai Medical Center, Miami
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Melanoma
Start date
2006-02-01
Primary completion
2009-09-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.